Erik Blok

Erik Blok

Erasmus University - Rotterdam / Netherlands
Others
AD Scientific Index ID: 4701756
Erasmus Universiteit
person_outline Erik Blok's MOST POPULAR ARTICLES
1-) Optimal duration of extended adjuvant endocrine therapy for early breast cancer; results of the IDEAL trial (BOOG 2006-05) EJ Blok, JR Kroep, E Meershoek-Klein Kranenbarg, ... JNCI: Journal of the National Cancer Institute 110 (1), 40-48, 2018 1292018
2-) Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytesM Sobral-Leite, I Salomon, M Opdam, DT Kruger, KJ Beelen, ...Breast Cancer Research 21, 1-12, 20191052019
3-) Cytoplasmic overexpression of HER2: a key factor in colorectal cancerEJ Blok, PJK Kuppen, JEM van Leeuwen, CFM SierClinical Medicine Insights: Oncology 7, CMO. S10811, 20131022013
4-) Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in EuropeEJ Blok, E Bastiaannet, WB Van den Hout, GJ Liefers, V Smit, JR Kroep, ...Cancer Treatment Reviews 62, 74-90, 2018822018
5-) Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trialMGM Derks, EJ Blok, C Seynaeve, JWR Nortier, EMK Kranenbarg, ...The Lancet Oncology 18 (9), 1211-1220, 2017702017